Esta traducción se está preparando. Mientras tanto, mostramos temporalmente la versión original en inglés.
Negocios · 3/6/19941 min de lectura
Skin Protectant Drug Products for Over-The-Counter Human Use; Astringent Drug Products; Final Monograph
Traducción automática local · Idioma original de la fuente
Resumen
The Food and Drug Administration (FDA) is issuing a final rule amending the monograph for over-the-counter (OTC) astringent drug products. This amendment updates the monograph to incorporate a United States Pharmacopeia (U.S.P.) name change for an active ingredient included in the monograph. This final rule is part of the ongoing review of OTC drug products conducted by FDA.
Idioma original de la fuente: Federal Register — Health and Human ServicesAbrir el comunicado original →